RXQ Compounding LLC recalls KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athe
Recalled August 14, 2019 · FDA recall D-1669-2019 · RXQ Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
Nationwide USA
Description
Lack of Assurance of Sterility
Product
KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →